Advances in understanding gray matter pathology in multiple sclerosis: Are we ready to redefine disease pathogenesis?

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Zivadinov, Robert ^a,b   Pirko, Istvan ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b JACOBS NEUROLOGICAL INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Atrophy; Clinical; Cortical; Double inversion recovery; Gray matter; Meningeal inflammation; Mri; Multiple sclerosis; Pathology; Subcortical; Treatment

Indexed keywords

BRAIN BIOPSY; BRAIN CORTEX; BRAIN DAMAGE; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DISEASE COURSE; EDITORIAL; ENVIRONMENTAL FACTOR; GRAY MATTER; HEREDITY; HUMAN; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; MULTIPLE SCLEROSIS; NEUROIMAGING; PATHOGENESIS; PHYSICAL DISABILITY; STAINING; BRAIN; IMMUNOLOGY; PATHOLOGY;

BRAIN; HUMANS; MULTIPLE SCLEROSIS;

EID: 84857713739     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-9     Document Type: Editorial

References (27)

1. Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 2007, 68(9):634-642. 10.1212/01.wnl.0000250267.85698.7a, 17325269.
2. Hulst HE, Geurts JJ. Gray matter imaging in multiple sclerosis: what have we learned?. BMC Neurol 2011, 11:153. 10.1186/1471-2377-11-153, 3262750, 22152037.
3. Walker CA, Huttner AJ, O'Connor KC. Cortical injury in multiple sclerosis; the role of the immune system. BMC Neurol 2011, 11:152. 10.1186/1471-2377-11-152, 3266198, 22145746.
4. Popescu B, Lucchinetti C. Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol
5. Horakova D, Kalincik T, Blahova-Dusankova J, Dolezal O. Clinical correlates of grey matter pathology in multiple sclerosis.
6. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003, 62(7):723-732.
7. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999, 122(Pt 1):17-26.
8. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001, 50(3):389-400. 10.1002/ana.1123, 11558796.
9. Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, Morra A, Rinaldi L, Romualdi C, Perini P, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007, 64(10):1416-1422. 10.1001/archneur.64.10.1416, 17923625.
10. Geurts JJ, Bo L, Pouwels PJ, Castelijns JA, Polman CH, Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005, 26(3):572-577.
11. Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005, 236(1):254-260. 10.1148/radiol.2361040450, 15987979.
12. Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002, 52(5):650-653. 10.1002/ana.10326, 12402265.
13. Antulov R, Carone DA, Bruce J, Yella V, Dwyer MG, Tjoa CW, Benedict RH, Zivadinov R. Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis. J Neuroimaging 2011, 21(3):210-218. 10.1111/j.1552-6569.2010.00482.x, 20412395.
14. Bo L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007, 64(1):76-80. 10.1001/archneur.64.1.76, 17210812.
15. Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Bruck W, Parisi JE, Scheithauer BW, Giannini C, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011, 365(23):2188-2197. 10.1056/NEJMoa1100648, 22150037.
16. Popescu BF, Bunyan RF, Parisi JE, Ransohoff RM, Lucchinetti CF. A case of multiple sclerosis presenting with inflammatory cortical demyelination. Neurology 2011, 76(20):1705-1710. 10.1212/WNL.0b013e31821a44f1, 21576686.
17. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128(Pt 11):2705-2712.
18. Geurts JJ, Bo L, Roosendaal SD, Hazes T, Daniels R, Barkhof F, Witter MP, Huitinga I, van der Valk P. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007, 66(9):819-827. 10.1097/nen.0b013e3181461f54, 17805012.
19. Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, Stadelmann C, Bruck W, Rauschka H, Schmidbauer M, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007, 17(1):38-44. 10.1111/j.1750-3639.2006.00041.x, 17493036.
20. Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005, 64(12):1101-1107. 10.1097/01.jnen.0000190067.20935.42, 16319720.
21. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130(Pt 4):1089-1104.
22. Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, Serafini B, Aloisi F, Roncaroli F, Magliozzi R, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011, 134(Pt 9):2755-2771.
23. Poloni G, Minagar A, Haacke EM, Zivadinov R. Recent developments in imaging of multiple sclerosis. Neurologist 2011, 17(4):185-204. 10.1097/NRL.0b013e31821a2643, 21712664.
24. Calabrese M, Rinaldi F, Poretto V, Gallo P. The puzzle of multiple sclerosis: gray matter finds its place. Expert Rev Neurother 2011, 11(11):1565-1568. 10.1586/ern.11.143, 22014135.
25. Seewann A, Kooi EJ, Roosendaal SD, Pouwels PJ, Wattjes MP, van der Valk P, Barkhof F, Polman CH, Geurts JJ. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012, 78:302-308. 10.1212/WNL.0b013e31824528a0, 22218278.
26. Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, Gass A, Huerga E, Moraal B, Pareto D, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 2011, 76:418-424. 10.1212/WNL.0b013e31820a0cc4, 21209373.
27. Geurts JJ, Stys PK, Minagar A, Amor S, Zivadinov R. Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci 2009, 282(1-2):12-20. 10.1016/j.jns.2009.01.018, 19249061.